ArticlePloS one2026
In vivo evaluation of binder jet 3D-Printed monetite, brushite, and octacalcium phosphate: A comparative study for bone regeneration in a rat calvarial defect model.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThree-dimensional (3D)-printed hydroxyapatite (3DP-HA), fabricated via binder jetting of calcium sulfate-based powders followed by phase conversion, has demonstrated bone regeneration efficacy in both in vitro and in vivo studies. However, the inherently low solubility nature of hydroxyapatite (HA) led to slow resorption, which may impede new bone formation. This study aimed to evaluate the in vivo bone regeneration efficacy of three newly developed resorbable 3D-printed calcium phosphate scaffolds, including brushite (3DP-BRU), monetite (3DP-MO), and octacalcium phosphate (3DP-OCP), fabricated using the similar technology as 3DP-HA.
methodsThe scaffolds were implanted in a rat calvarial defect model and compared with control groups, including 3DP-HA and two commercial bone grafts: bovine bone graft (BBG) and freeze-dried bone allograft (FDBA). Bone regeneration and material resorption were assessed using micro-computed tomography (micro-CT), histological, and immunohistochemical analyses.
resultsMicro-CT and histological evaluations demonstrated that 3DP-MO and 3DP-BRU scaffolds significantly enhanced new bone formation and bone cell activities within the defect sites compared with the controls. Furthermore, both 3DP-MO and 3DP-BRU exhibited considerably lower residual graft material compared to the controls, indicating superior resorption characteristics.
conclusionResorbable 3D-printed calcium phosphate scaffolds, particularly 3DP-MO and 3DP-BRU, exhibit superior resorbability and enhanced bone regeneration compared with conventional materials. These findings highlight their potential as promising biomaterials for clinical application in bone defect repair.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.